Baird Financial Group, Inc. Pfizer Inc Transaction History

Baird Financial Group, Inc.

$47.3 Billion
Q1 2024

A detailed history of Baird Financial Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Baird Financial Group, Inc. holds 6,525,663 shares of PFE stock, worth $183 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

6,525,663

Previous 6,141,689 6.25%

Holding current value

$183 Million

Previous $177 Million 2.41%

% of portfolio

0.38%

Previous 0.41%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $9.94 Million - $11.4 Million	383,974 Added 6.25%	6,525,663 $181 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $24.8 Million - $32.2 Million	-948,812 Reduced 13.38%	6,141,689 $177 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $5.83 Million - $6.81 Million	-181,625 Reduced 2.5%	7,090,501 $235 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $39.2 Million - $45.4 Million	-1,086,205 Reduced 13.0%	7,272,126 $267 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $7.84 Million - $10.2 Million	199,129 Added 2.44%	8,358,331 $341 Million

Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $133,993 - $163,572	3,062 Added 0.04%	6,905,683 $302 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $1.76 Million - $2.08 Million	37,743 Added 0.55%	6,902,621 $362 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $9.87 Million - $12.2 Million	-215,719 Reduced 3.05%	6,864,878 $355 Million
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $788,302 - $1.17 Million	19,078 Added 0.27%	7,080,597 $418 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $7.31 Million - $9.4 Million	186,335 Added 2.71%	7,061,519 $304 Million
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $2.54 Million - $2.88 Million	70,697 Added 1.04%	6,875,184 $269 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $5.92 Million - $6.68 Million	176,750 Added 2.67%	6,804,487 $247 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $9.28 Million - $11.8 Million	277,147 Added 4.36%	6,627,737 $244 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $5.06 Million - $5.93 Million	159,244 Added 2.57%	6,350,590 $233 Million
Q2 2020 Oct 22, 2020	BUY	$30.12 - $36.54 $20.1 Million - $24.4 Million	666,662 Added 12.07%	6,191,346 $202 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $7.93 Million - $9.62 Million	-263,169 Reduced 4.55%	5,524,684 $198 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $17.4 Million - $24.9 Million	644,430 Added 12.53%	5,787,853 $189 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $935,092 - $1.06 Million	-28,405 Reduced 0.55%	5,143,423 $202 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $6.6 Million - $8.56 Million	-203,086 Reduced 3.78%	5,171,828 $186 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $128 Million - $144 Million	3,473,916 Added 182.74%	5,374,914 $233 Million
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $8.63 Million - $9.48 Million	230,157 Added 13.77%	1,900,998 $80.7 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $2.72 Million - $3.1 Million	70,707 Added 4.42%	1,670,841 $72.9 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $1.48 Million - $1.8 Million	-42,935 Reduced 2.61%	1,600,134 $70.8 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $4.51 Million - $4.81 Million	-136,899 Reduced 7.69%	1,643,069 $59.6 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $2.32 Million - $2.69 Million	72,642 Added 4.25%	1,779,968 $63.2 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $2.05 Million - $2.18 Million	61,752 Added 3.75%	1,707,326 $61.8 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $1.09 Million - $1.2 Million	-35,106 Reduced 2.09%	1,645,574 $58.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,680,680	1,680,680 $56.5 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Pfizer Inc Transaction History